MedTrace Logo

EZIO Compared to Central Venous Lines for Emergency Vascular Access

NCT00785252 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-09-28

No results posted yet for this study

Summary

Multicenter randomized study to compare powered intraosseous access to standard central line access for the administration of fluids and drugs for patients in the Emergency Dept.

Conditions

  • Catheters, Indwelling
  • Central Venous Line
  • Intraosseous Needle

Interventions

DEVICE

Powered Intraosseous device (EZIO)

EZIO

DEVICE

standard central line

placement of a central line

Sponsors & Collaborators

  • Vidacare Corporation

    collaborator INDUSTRY

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Jeremty Brown, MD · George Washington University

  • Jeremy Brown · Dept of Emergency Medicine, GWU

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00785252 on ClinicalTrials.gov